Alexandr Myasnikov

513 total citations
6 papers, 65 citations indexed

About

Alexandr Myasnikov is a scholar working on Genetics, Infectious Diseases and Epidemiology. According to data from OpenAlex, Alexandr Myasnikov has authored 6 papers receiving a total of 65 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 2 papers in Infectious Diseases and 2 papers in Epidemiology. Recurrent topics in Alexandr Myasnikov's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Respiratory viral infections research (2 papers). Alexandr Myasnikov is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Respiratory viral infections research (2 papers). Alexandr Myasnikov collaborates with scholars based in Russia, Canada and United States. Alexandr Myasnikov's co-authors include С. А. Бернс, Haifa Kathrin Al‐Ali, Lynda Foltz, Ershov Fi, Pierre Zachée, Francesco Passamonti, Francesco Mannelli, David M. Ross, Atanas Radinoff and Ranjan Tiwari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Leukemia.

In The Last Decade

Alexandr Myasnikov

5 papers receiving 64 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexandr Myasnikov Russia	4	45	35	28	13	12	6	65
Pablo Muxí Uruguay	5	28 0.6×	76 2.2×	74 2.6×	5 0.4×	7 0.6×	8	106
Joshua Weinstock United States	3	29 0.6×	45 1.3×	18 0.6×	6 0.5×	5 0.4×	6	79
Jordan J Clark United States	3	55 1.2×	31 0.9×	35 1.3×	16 1.2×	33 2.8×	9	85
Anitria Cotton United States	3	26 0.6×	30 0.9×	22 0.8×	3 0.2×	11 0.9×	7	65
Olivia Chandesris France	3	18 0.4×	27 0.8×	22 0.8×	3 0.2×	11 0.9×	4	53
Marta Riva Italy	4	20 0.4×	19 0.5×	8 0.3×	7 0.5×	13 1.1×	10	42
Thomas Chalopin France	5	7 0.2×	19 0.5×	19 0.7×	5 0.4×	6 0.5×	20	54
A. Prezotti Brazil	4	11 0.2×	32 0.9×	9 0.3×	12 0.9×	16 1.3×	9	65
Christopher R. Reilly United States	4	22 0.5×	37 1.1×	57 2.0×	3 0.2×	5 0.4×	10	122
Zhaoling Xuan China	5	16 0.4×	27 0.8×	28 1.0×	11 0.8×	4 0.3×	5	103

Countries citing papers authored by Alexandr Myasnikov

Since Specialization

Citations

This map shows the geographic impact of Alexandr Myasnikov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandr Myasnikov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandr Myasnikov more than expected).

Fields of papers citing papers by Alexandr Myasnikov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandr Myasnikov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandr Myasnikov. The network helps show where Alexandr Myasnikov may publish in the future.

Co-authorship network of co-authors of Alexandr Myasnikov

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandr Myasnikov. A scholar is included among the top collaborators of Alexandr Myasnikov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandr Myasnikov. Alexandr Myasnikov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Myasnikov, Alexandr, et al.. (2022). Preventive effectiveness of nasal interferon-gamma among adult volunteers against acute respiratory viral infections, including COVID-19. Immunologiya. 43(3). 301–311.

2.

Myasnikov, Alexandr, et al.. (2021). Interferon gamma in the treatment of patients with moderate COVID-19. SHILAP Revista de lepidopterología. 66(1). 47–54. 13 indexed citations

3.

Cervantes, Francisco, David M. Ross, Atanas Radinoff, et al.. (2021). Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study. Leukemia. 35(12). 3455–3465. 39 indexed citations

4.

Бернс, С. А., et al.. (2019). The efficacy and safety of gamma-interferon in the treatment of community-acquired pneumonia: results of the open randomized trial IN/100000-317. 7(4). 110–125. 2 indexed citations

5.

Cervantes, F., Atanas Radinoff, Francesco Passamonti, et al.. (2019). PS1465 SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN PATIENTS WITH MYELOFIBROSIS (MF) AND ANEMIA (HB <10 G/DL): RESULTS AT WEEK (WK) 24 OF THE REALISE TRIAL. HemaSphere. 3(S1). 675–676. 3 indexed citations

6.

Mittelman, Moshe, Sarit Assouline, Evangelos Briasoulis, et al.. (2012). Eltrombopag Treatment of Thrombocytopenia in Advanced Myelodysplastic Syndromes and Acute Myeloid Leukemia: Results of the 8-Week Open-Label Part of an Ongoing Study. Blood. 120(21). 3822–3822. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact